NCT03711279 2024-02-29A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue SarcomaJiangsu HengRui Medicine Co., Ltd.Phase 2 Terminated99 enrolled 10 charts
NCT04074564 2023-10-23MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue SarcomaHRYZ Biotech Co.Phase EARLY_PHASE1 Unknown60 enrolled